FDA Adverse Event Injury Summary report: N

STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

MDR report key: 6052852 · Received October 24, 2016

Report

Report Number
3007566237-2016-03699
Event Type
Injury
Date Received
October 24, 2016
Date of Event
August 2, 2016
Report Date
October 24, 2016
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

CONCOMITANT PRODUCTS: PRODUCT ID: NEU_UNKNOWN_LEAD, PRODUCT TYPE: LEAD.

Description of Event or Problem · 1

FARRIS, S.M., GIROUX, M.L. RAPID ASSESSMENT OF GAIT AND SPEECH AFTER SUBTHALAMIC DEEP BRAIN STIMULATION. SURGICAL NEUROLOGY INTERNATIONAL. 2016. 7(SUPPL 19):S545-550. DOI: 10.4103/2152-7806.187532. SUMMARY: WE RETROSPECTIVELY REVIEWED 29 PATIENTS THAT HAD IMPROVEMENT IN GAIT AND/OR SPEECH WITHIN 30 MIN AFTER TURNING STIMULATION OFF. CLINICAL DATA ANALYZED INCLUDE UNIFIED PARKINSON'S DISEASE (PD) RATING SCALE MOTOR SCORES AND STIMULATION PARAMETERS BEFORE AND AFTER ADJUSTING STIMULATION. ALL PATIENTS RECEIVED ELECTRODE EFFICACY AND SIDE EFFECT THRESHOLD TESTING. STIMULATION PARAMETERS WERE ADJUSTED TO MAXIMIZE EFFICACY, AVOID SIDE EFFECTS, AND MAXIMIZE BATTERY LONGEVITY. REPORTED EVENTS: A PATIENT WITH BILATERAL DEEP BRAIN STIMULATION (DBS) OF THE SUBTHALAMIC NUCLEUS (STN) FOR IDIOPATHIC PARKINSON'S DISEASE (PD) EXPERIENCED STIMULATION INDUCED SPEECH AND GAIT DEFICITS WHICH IMPROVED WITHIN 30 MINUTES OF TURNING OFF STIMULATION. THE AUTHORS REPORTED THAT THIS PATIENT REQUIRED A LEAD REVISION DUE TO UNAVOIDABLE STIMULATION SIDE EFFECTS. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE REPORTED EVENT WITH ANY PREVIOUSLY REPORTED EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
701940 STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC NEUROMODULATION NEU_INS_STIMULATOR UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention